Biofrontera Inc. (BFRIW) bonds
BFRIWNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as BFRI
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 10/30
$0.00+0.00 (0.00%)
Close on Oct 30, 2026Market cap $12.96MP/E –Yield –
Debt
Borrowings on the balance sheet, Jun 30, 2026
Biofrontera reports no long-term debt line
Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.
Notes and loans outstanding
As tagged in Biofrontera's 10-Q for the period ended Jun 30, 2026
| Issue | Coupon | Amount issued | Carrying value |
|---|---|---|---|
| Business Loanand Security Agreement | – | $2.00M | – |
| Convertible Notes Payable Convertible | – | $4.20M | $4.60M |
| Senior Secured Convertible Notes Convertible at $1 a share | 10.00% | $4.20M | – |
Companies tag their debt differently: some list every note, others group notes by issuance year or by type, so the list may not add up to total debt. Notes that matured before today are hidden. Source: 10-Q.